---
schema_version: "secwatch.filing_event.v1"
accession: "0001477932-23-004119"
form_type: "8-K"
ticker: "COSM"
cik: "0001474167"
company_name: "Cosmos Health Inc."
filed_at: "2023-05-31T23:59:59+00:00"
generated_at: "2026-06-14T10:21:30.910282+00:00"
event_type: "m_and_a"
sentiment: "neutral"
materiality_score: 0.45
calibrated_materiality_score: 0.45
confidence: "high"
source: SEC EDGAR
---

# Cosmos Health to acquire Docpharm GmbH for €800K cash plus €1M credit line

## Summary
- Purchase price €800,000 in cash to Docpharm owners; additional €1,000,000 credit line for working capital.
- Closing subject to due diligence, definitive SPA, board/stockholder approvals, and PCAOB-auditable financials.
- Exclusivity through July 15, 2023; Docpharm is an ISO/GDP-certified German pharmaceutical distributor since 1995.
- Current managing directors to remain; new service agreements with equal or better economic terms.
- Cosmos to bear costs of due diligence and audit as part of the transaction.

## SEC filing metadata
- accession: 0001477932-23-004119
- form_type: 8-K
- ticker: COSM
- cik: 0001474167
- company_name: Cosmos Health Inc.
- filed_at: 2023-05-31T23:59:59+00:00
- event_type: m_and_a
- sentiment: neutral
- materiality_score: 0.45
- calibrated_materiality_score: 0.45
- confidence: high
- sec_items: 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1474167/000147793223004119/0001477932-23-004119-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1474167/000147793223004119/cosm_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001477932-23-004119
- JSON: https://secwatch.observer/filing/0001477932-23-004119.json
- Plain text: https://secwatch.observer/filing/0001477932-23-004119.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.